Clik here to view.
Aster Guardians Global Nursing Award 2024 is Now Open for Entry Worldwide,...
DUBAI, United Arab Emirates In its continued efforts to recognize the contribution of nurses to humanity and the healthcare community, Aster DM Healthcare has announced the third edition of the...
View ArticleClik here to view.
2024年Aster Guardians全球护理奖现已在全球范围内开放报名，一名护士将获得25万美元的奖金
阿拉伯联合酋长国迪拜 (美国商业资讯)– 为了表彰护士对人们和医疗保健领域的贡献，Aster DM Healthcare宣布举办第三届Aster Guardians全球护理奖。该奖项邀请来自世界各地的注册护士通过在www.asterguardians.com上提交有关其工作成就的提名来进行申请。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
大賞受賞者に25万ドルが贈られる2024年アスター・ガーディアンズ世界看護賞、世界中からのエントリー受け付けを開始
アラブ首長国連邦・ドバイ （ビジネスワイヤ） — 人類と医療界への看護師の貢献を称える継続的な取り組みとして、アスターDMヘルスケアは第3回アスター・ガーディアンズ世界看護賞の開催を発表しました。世界中の正看護師は、www.asterguardians.comに推薦書を提出することで賞に応募することができます。...
View ArticleClik here to view.
Takeda Announces Approval of CUVITRU™ Subcutaneous Immunoglobulin in Japan...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of CUVITRU™ [Immune Globulin Subcutaneous...
View ArticleClik here to view.
A research paper from COGNANO with co-authors from Google on a large-scale...
KYOTO, Japan Antibodies are the most important therapeutic modality in drug discovery because there is no substance that binds to target molecules (antigens) as precisely and strongly as antibodies....
View ArticleClik here to view.
Zatolmilast, an Investigational Treatment for Fragile X Syndrome, Receives...
OSAKA, Japan Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.; hereafter “Shionogi”) announced the U.S. Food and Drug Administration (FDA) has...
View ArticleClik here to view.
JCR Pharmaceuticals Announces 52-Week Interim Data from its Global Phase I/II...
HYOGO, Japan JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) announced today key results from the 52-week interim data of its global phase I/II study with JR-171...
View ArticleClik here to view.
PHCとJCRファーマ、成長ホルモン治療における服薬管理アプリケーションソフトウェア「めろん日記®」のアップデート第二弾を公開
東京 & 兵庫県芦屋 （ビジネスワイヤ） — PHC株式会社 診断薬事業部（本社：東京都港区、代表取締役社長：中村 伸朗、以下「PHC IVD」）と、JCRファーマ株式会社（本社：兵庫県芦屋市、代表取締役会長兼社長：芦田...
View ArticleClik here to view.
Ascend Capital Partners Acquires Majority Stake in Seoul Medical Group (SMG)
NEW YORK Ascend Capital Partners (“Ascend”), a healthcare focused private equity partnership, today announced that it has acquired a majority stake in Seoul Medical Group (SMG), one of the country’s...
View ArticleClik here to view.
Vyvo Smart Chain Announces Listing of $VSC Utility Coin on Top-Rated...
SINGAPORE Vyvo Smart Chain (VSC), a HealthFi ecosystem that leverages Web3 technology to promote positive lifestyle habits, today announced the listing of its native utility coin, $VSC, on premier...
View ArticleClik here to view.
NEXT Oncology and MediLink Therapeutics Take “Team Approach” to Next Level on...
SAN ANTONIO & CAMBRIDGE, Mass. MediLink Therapeutics and NEXT Oncology are collaborating on a Phase 1 First in Human Clinical trial for an antibody drug conjugate (ADC) that shows great promise...
View ArticleClik here to view.
Fujirebio and Sysmex Enter into Basic Agreement on Business Collaboration in...
TOKYO & KOBE, Japan Fujirebio Holdings, Inc. (HQ: Minato-ku, Tokyo; President & CEO: Goki Ishikawa) and Sysmex Corporation (HQ: Kobe, Japan; President: Kaoru Asano) announce that they have...
View ArticleClik here to view.
Gritgen Therapeutics Launches Commercial GMP Facility in Suzhou, China
SUZHOU, China Gritgen Therapeutics Co., Ltd. (“Gritgen”), a biotechnology company focused on discovering and developing innovative gene therapy products, announces the successful validation and...
View ArticleClik here to view.
AIメディカルサービス、ベトナムを代表する研究機関と共同研究契約を締結
東京 （ビジネスワイヤ） — 内視鏡の画像診断支援AI（人工知能）を開発する株式会社AIメディカルサービス（本社：東京都豊島区、代表取締役 CEO：多田 智裕、以下「AIM」）とThe Institute of Gastroenterology and Hepatology（所在地：ベトナム、10th Floor VCCI Tower, 9 Dao Duy Anh,...
View ArticleClik here to view.
AI Medical Service Inc. Signs Joint Research Agreement with Leading...
TOKYO AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research agreement with Institute of...
View ArticleClik here to view.
EpimAb Biotherapeutics and Almirall Announce Bispecific Antibody License...
SHANGHAI & BARCELONA, Spain EpimAb Biotherapeutics, a clinical stage biopharmaceutical company specializing in the development of multispecific antibodies, and Almirall, a global...
View ArticleClik here to view.
AI Medical Service Inc.与越南领先医疗机构签署联合研究协议
东京 (美国商业资讯)– 专门从事诊断性内窥镜人工智能开发的医疗初创企业AI MEDICAL SERVICE INC.（以下简称“AIM”）与越南胃肠病学和肝病学研究所（以下简称“IGH”）签署了联合研究协议，将于2023年10月27日开始研究活动。AIM是第一家与IGH签署内窥镜人工智能领域联合研究协议的日本公司，而IGH则是迄今为止AIM与之合作的第一家越南研究所1。...
View ArticleClik here to view.
Half a Million Factory Workers in Low-Income Countries Have Vision Screened...
NEW YORK On World Sight Day, an annual day of awareness to focus on vision impairment and eye health, the social enterprise VisionSpring has announced that it has screened the vision of half a...
View ArticleClik here to view.
教育でコロンビアの未来に力を：コロンビアの幼児期発達におけるADFDの取り組み
アラブ首長国連邦アブダビ （ビジネスワイヤ） — アブダビ開発基金（ADFD）が1,050万米ドルを割り当てて支援するコロンビアの「幼児発達センター（ECDC）プロジェクト」は、持続可能な開発目標（SDGs）に対するアラブ首長国連邦（UAE）の深い取り組みの証です。このイニシアチブの結果、初等教育と保健インフラが目覚ましく進歩して地域社会に変革的な影響をもたらしています。...
View ArticleClik here to view.
HARMAN Launches New Private Large Language Model for Healthcare Industry-...
BENGALURU, India HARMAN, a wholly-owned subsidiary of Samsung Electronics Co., Ltd. focused on connected technologies for automotive, consumer, and enterprise markets, announced that its Digital...
View Article